Literature DB >> 16121827

Taking antidepressants during late pregnancy. How should we advise women?

S Kalra1, A Einarson, Gideon Koren.   

Abstract

QUESTION: In light of recent negative media attention to antidepressant use during late pregnancy, several of my patients have either discontinued or are considering discontinuing their antidepressant medications. How can I best counsel these patients on taking antidepressants during late pregnancy? ANSWER: Antidepressant use during the third trimester has been associated occasionally with a transient neonatal withdrawal-like syndrome characterized by jitteriness, self-limiting respiratory difficulties, and problems with feeding. When counseling patients, the risk of these adverse effects must be weighed against the risks associated with untreated depression during late pregnancy. Abrupt discontinuation of psychotropic medications has been associated with both physical (eg, withdrawal) and psychological (eg, suicidal thoughts) symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16121827      PMCID: PMC1479505     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  Neonate characteristics after maternal use of antidepressants in late pregnancy.

Authors:  Bengt Källén
Journal:  Arch Pediatr Adolesc Med       Date:  2004-04

Review 2.  Clinical management of antidepressant discontinuation.

Authors:  J F Rosenbaum; J Zajecka
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

3.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

4.  Perinatal outcome following third trimester exposure to paroxetine.

Authors:  Adriana Moldovan Costei; Eran Kozer; Tommy Ho; Shinya Ito; Gideon Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2002-11

5.  Sex differences in rates of depression: cross-national perspectives.

Authors:  M M Weissman; R Bland; P R Joyce; S Newman; J E Wells; H U Wittchen
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

6.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

7.  Managing depression in pregnancy.

Authors:  A Buist
Journal:  Aust Fam Physician       Date:  2000-07

Review 8.  Perinatal risks of untreated depression during pregnancy.

Authors:  Lori Bonari; Natasha Pinto; Eric Ahn; Adrienne Einarson; Meir Steiner; Gideon Koren
Journal:  Can J Psychiatry       Date:  2004-11       Impact factor: 4.356

9.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Authors:  Tim F Oberlander; Shaila Misri; Colleen E Fitzgerald; Xanthoula Kostaras; Dan Rurak; Wayne Riggs
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

10.  Birth outcomes after prenatal exposure to antidepressant medication.

Authors:  Victoria Hendrick; Lynne M Smith; Rita Suri; Sun Hwang; Desiree Haynes; Lori Altshuler
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661

View more
  2 in total

Review 1.  The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant.

Authors:  Angelica L Kloos; Abigail Dubin-Rhodin; Jillan Cantor Sackett; Thomas A Dixon; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

Review 2.  Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.

Authors:  Richard A Epstein; Katherine M Moore; William V Bobo
Journal:  Drug Healthc Patient Saf       Date:  2014-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.